Original Research

The Role of Adolescent Acne Treatment in Formation of Scars Among Patients With Persistent Adult Acne: Evidence From an Observational Study

Author and Disclosure Information

 

References


Data Collection
To obtain data with the highest degree of reliability, 3 sources of information were used: (1) a detailed medical interview conducted by one experienced dermatologist (E.C.) at our dermatology center at the first visit in all study participants, (2) a clinical examination that yielded results necessary for the assessment of scars using a method outlined by Jacob et al, 12 and (3) information included in available medical records. These data were then statistically analyzed.

Statistical Analysis
The results were presented as frequency plots, and a Fisher exact test was conducted to obtain a statistical comparison of the distributions of analyzed data. Unless otherwise indicated, 5% was adopted as the significance level. The statistical analysis was performed using Stata 14 software (StataCorp LLC, College Station, Texas).

Results

Incidence of Different Forms of Adult Acne
To analyze the onset of acne, patients were categorized into 1 of 2 groups: those with persistent adult acne (81.98%) and those with late-onset adult acne (ie, developed after 25 years of age)(18.02%).

Age at Initiation of Dermatologic Treatment
Of the patients with persistent adult acne, 31.87% first visited a dermatologist the same year that the first acne lesions appeared, 36.26% postponed the first visit by at least 5 years (Figure 1), and 23.08% started treatment at least 10 years after acne first appeared. Among patients with persistent adult acne, 76.92% began dermatologic treatment before 25 years of age, and 23.08% began treatment after 25 years of age. Of the latter, 28.57% did not start therapy until they were older than 35 years.

Figure 1. Initiation of dermatologic treatment for patients with persistent adult acne (n=91).

Severity of Adolescent Acne
In the persistent adult acne group, the severity of adolescent acne was assessed during the medical interview as well as detailed histories in medical records. The activity of acne was evaluated at 2-year intervals with the use of a 10-point scale: 1 to 3 points indicated mild acne (7.69% of patients), 4 to 6 points indicated moderate acne (24.18%), and 7 to 10 points indicated severe acne (68.13%).

Treatment of Persistent Acne in Adolescence
Treatment was comprised of oral therapy with antibiotics, isotretinoin, and/or application of topical retinoids (sometimes supported with OCPs). Monotherapy was the standard of treatment more than 25 years ago when patients with persistent adult acne were treated as adolescents or young adults. As many as 43.96% of patients with persistent adult acne did not receive any of these therapies before 25 years of age; rather, they used antiacne cosmetics or beauty procedures. Furthermore, 50.55% of patients were treated with oral antibiotics (Figure 2). Topical retinoids were used in 19.78% of patients and isotretinoin was used in 16.48%. Incidentally, OCPs were given to 26.5%. In the course of adolescent acne, 31.87% of patients received 2 to 4 courses of treatment with either antibiotics or retinoids (oral or topical), and 5.49% were treated with 5 or more courses of treatment (Figure 3). The analysis of each treatment revealed that only 1 patient received 4 courses of isotretinoin. Five courses of oral antibiotics were given in 1 patient, and 3 courses of topical retinoids were given in the same patient.

Figure 2. Patients with persistent adult acne treated with oral antibiotics, isotretinoin, and topical retinoids before 25 years of age (n=91).

Figure 3. Total number of oral antibiotics, isotretinoin, and topical retinoid treatments before 25 years of age in patients with persistent adult acne (n=91).

Recommended Reading

Investigational laser for acne treatment targets sebaceous gland, spares dermis
MDedge Dermatology
Females with acne stay on spironolactone longer than antibiotics in real-world usage study
MDedge Dermatology
Severe respiratory failure strikes healthy teens on trimethoprim-sulfamethoxazole
MDedge Dermatology
Acetyl-coenzyme-A carboxylase inhibition shows early promise for acne vulgaris
MDedge Dermatology
Treatment Consideration for US Military Members With Skin Disease
MDedge Dermatology
Ovarian reserve markers fall on isotretinoin, but rebound after stopping treatment
MDedge Dermatology
Severe Acne Fulminans Following Low-Dose Isotretinoin and Testosterone Use
MDedge Dermatology
No increased risk of psychiatric problems tied to isotretinoin
MDedge Dermatology
Acne in women: What new insights tell us
MDedge Dermatology
What’s New in the Management of Acne Vulgaris
MDedge Dermatology